The Art of Effective R&D Transformation

Productive R&D is the lifeblood of leading pharmaceutical and biotech companies, and with increased pressure to create meaningful new medicines, R&D effectiveness can always be improved.

In our recent webinar, John Rountree, Managing Partner at Novasecta, was joined by a panel of pharma company R&D Heads, who shared their experiences on how they have been successful in transforming the performance of their R&D organisations.

The panel – Claude Bertrand (Executive Vice President R&D & CSO at Servier), Johan Luthman (Executive Vice President R&D at Lundbeck) and Dhaval Patel (Executive Vice President & CSO at UCB) discussed:

  • The reasons for transforming R&D.
  • The changes that have the most impact.
  • How transformation is motivated and sustained.

If you are a Head of R&D, in an R&D Leadership position, or a CEO or COO in an innovative pharma or biotech company, you will definitely want to watch this on-demand webinar.

Click here to watch now.